NK Cell Levels Correlate with Disease Activity in Patients with Multiple Sclerosis on Ocrelizumab/Rituximab Therapy.

Simone Dal BelloSimone LorenzutEmma SaccomanoYan TereshkoGian Luigi GigliCarlo Ennio PucilloMariarosaria Valente

Published in: Pharmaceuticals (Basel, Switzerland) (2024)

Lower percentage levels of NK cells 3 months after anti-CD20 infusion correlate with the presence of disease activity 6 months after therapy, confirming a possible protective role of NK cells in MS.

Keyphrases

nk cells
disease activity
rheumatoid arthritis
systemic lupus erythematosus
rheumatoid arthritis patients
ankylosing spondylitis
juvenile idiopathic arthritis
multiple sclerosis
mass spectrometry
ms ms
low dose
cell therapy
replacement therapy